Novartis (NVSEF) Stock Price, News & Analysis
Company Description
NVSEF has gained 26.1% over the past year. Shares last traded at $164.25.
For FY2025, Novartis reported net income of $14.0B and diluted earnings per share of $7.15.
This page collects what Stock Titan holds for NVSEF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Novartis (NVSEF) last closed at $164.25. Over the past 12 months, NVSEF has gained 26.1%.
NVSEF Rankings
Latest News
SEC Filings
Novartis has filed 5 recent SEC filings, including 4 Form 6-K, 1 Form 144. The most recent filing was submitted on September 1, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all NVSEF SEC filings →
Financial Highlights
net income was $14.0B. Diluted earnings per share stood at $7.15. The company generated $19.1B in operating cash flow. With a current ratio of 1.12, the company maintains adequate short-term liquidity.
Upcoming Events
Short Interest History
Short interest in Novartis (NVSEF) currently stands at 1.2 million shares, down 1.0% from the previous reporting period, representing 0.1% of the float. Since September 2025, short interest has decreased by 41.3%. This relatively low short interest suggests limited bearish sentiment. With 681.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Novartis (NVSEF) currently stands at 681.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 433.2% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 4.4 to 1000.0 days.